Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Olympus ( (JP:7733) ) has shared an announcement.
Olympus Corporation’s board has approved a share repurchase program and set the specific terms for an initial transaction using the Tokyo Stock Exchange’s ToSTNeT-3 off-auction system. The company plans to buy back up to 38,948,300 common shares, representing 3.54% of its outstanding stock, for a maximum of ¥60 billion at the May 12 closing price, with execution scheduled for the 8:45 a.m. session on May 13, 2026.
This transaction forms part of a broader buyback authorization allowing Olympus to repurchase up to 46 million shares, or 4.18% of its float, for as much as ¥60 billion between May 13, 2026 and March 31, 2027. The program, to be carried out via both off-auction and open-market purchases, underscores management’s focus on capital efficiency and shareholder returns, while execution remains contingent on market conditions and available sell orders.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a Japanese manufacturer operating primarily in the medical technology and precision equipment sectors, best known for its endoscopes, medical imaging systems, and scientific solutions. The company is listed on the Tokyo Stock Exchange and targets global healthcare and life science markets, where it competes as a leading provider of minimally invasive diagnostic and therapeutic devices.
Average Trading Volume: 6,650,062
Technical Sentiment Signal: Sell
Current Market Cap: Yen1730B
For a thorough assessment of 7733 stock, go to TipRanks’ Stock Analysis page.

